Madrigal Pharmaceuticals (MDGL) News Today $425.06 +0.20 (+0.05%) Closing price 08/27/2025 04:00 PM EasternExtended Trading$423.00 -2.06 (-0.48%) As of 07:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MDGL Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Reviewing Madrigal Pharmaceuticals (NASDAQ:MDGL) and BioNxt Solutions (OTCMKTS:BNXTF)4 hours ago | americanbankingnews.comMadrigal Pharmaceuticals (NASDAQ:MDGL) Reaches New 52-Week High - Should You Buy?August 27 at 10:27 AM | marketbeat.comMadrigal Pharmaceuticals, Inc. $MDGL Stock Position Decreased by Price T Rowe Associates Inc. MDAugust 27 at 5:03 AM | marketbeat.comMadrigal Pharmaceuticals (NASDAQ:MDGL) Price Target Raised to $554.00 at TD CowenAugust 27 at 2:01 AM | americanbankingnews.comMadrigal Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)August 26 at 8:23 PM | benzinga.comMadrigal Pharmaceuticals, Inc. $MDGL is University of Wisconsin Foundation's 3rd Largest PositionAugust 26 at 7:23 AM | marketbeat.comDo You Believe in the Upside Potential of Madrigal Pharmaceuticals (MDGL)?August 25 at 10:11 AM | insidermonkey.comCandriam S.C.A. Buys New Position in Madrigal Pharmaceuticals, Inc. $MDGLAugust 24, 2025 | marketbeat.comNuveen LLC Buys New Shares in Madrigal Pharmaceuticals, Inc. $MDGLAugust 23, 2025 | marketbeat.comMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Receives $439.71 Average Target Price from BrokeragesAugust 23, 2025 | americanbankingnews.comMadrigal Pharmaceuticals (NASDAQ:MDGL) Price Target Raised to $485.00 at JMP SecuritiesAugust 22, 2025 | marketbeat.comWilliam John Sibold Sells 7,616 Shares of Madrigal Pharmaceuticals (NASDAQ:MDGL) StockAugust 22, 2025 | insidertrades.comB. Riley Brokers Increase Earnings Estimates for MDGLAugust 22, 2025 | marketbeat.comAmerican Century Companies Inc. Purchases 21,457 Shares of Madrigal Pharmaceuticals, Inc. $MDGLAugust 22, 2025 | marketbeat.comB. Riley Has Optimistic Outlook of MDGL Q3 EarningsAugust 22, 2025 | americanbankingnews.comMadrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)August 21, 2025 | globenewswire.comMadrigal Pharmaceuticals (NASDAQ:MDGL) Director Bros. Advisors Lp Baker Acquires 59,901 SharesAugust 21, 2025 | insidertrades.comGroupama Asset Managment Purchases 9,128 Shares of Madrigal Pharmaceuticals, Inc. $MDGLAugust 21, 2025 | marketbeat.comMadrigal Pharmaceuticals (NASDAQ:MDGL) Hits New 1-Year High - Here's WhyAugust 21, 2025 | marketbeat.comRussell Investments Group Ltd. Has $9.80 Million Holdings in Madrigal Pharmaceuticals, Inc. $MDGLAugust 21, 2025 | marketbeat.comMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Given Average Recommendation of "Moderate Buy" by BrokeragesAugust 21, 2025 | marketbeat.comMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) General Counsel Sells $479,624.24 in StockAugust 20, 2025 | marketbeat.comMadrigal Pharmaceuticals price target raised to $485 from $483 at Citizens JMPAugust 20, 2025 | msn.comMadrigal gets EU nod for its MASH treatmentAugust 20, 2025 | msn.comMadrigal Pharmaceuticals (NASDAQ:MDGL) Shares Gap Down Following Insider SellingAugust 20, 2025 | marketbeat.comMadrigal Shares Slip After FDA Clears Novo Nordisk’s Wegovy for MASHAugust 20, 2025 | msn.comMadrigal gets conditional marketing authorization for Rezdiffra from ECAugust 20, 2025 | msn.comMadrigal Receives European Commission Approval for Rezdiffra™ (resmetirom) for the Treatment of MASH with Moderate to Advanced Liver FibrosisAugust 20, 2025 | finance.yahoo.comMadrigal Receives European Commission Approval for Rezdiffraâ„¢ (resmetirom) for the Treatment of MASH with Moderate to Advanced Liver FibrosisAugust 19, 2025 | globenewswire.comInvesco Ltd. Purchases 3,860 Shares of Madrigal Pharmaceuticals, Inc. $MDGLAugust 19, 2025 | marketbeat.comShannon T. Kelley Sells 1,304 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) StockAugust 19, 2025 | insidertrades.comMadrigal Pharmaceuticals (NASDAQ:MDGL) Shares Gap Down on Insider SellingAugust 19, 2025 | americanbankingnews.comMadrigal stock falls after Novo Nordisk’s Wegovy wins FDA approval for MASHAugust 18, 2025 | finance.yahoo.comNovo Nordisk Rallied On Wegovy's Newest Approval. But This Rival Rallied More.August 18, 2025 | msn.comMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Stock Holdings Increased by Sei Investments Co.August 18, 2025 | marketbeat.comNovo Nordisk (NVO) Stock Gains as Wegovy Drug Gets FDA Nod for Liver DiseaseAugust 18, 2025 | msn.comMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Director Kenneth Bate Sells 10,000 SharesAugust 18, 2025 | americanbankingnews.comMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Director Sells $3,652,000.00 in StockAugust 17, 2025 | marketbeat.comLord Abbett & CO. LLC Acquires 69,107 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)August 17, 2025 | marketbeat.comDeutsche Bank AG Has $8.59 Million Holdings in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)August 17, 2025 | marketbeat.comNovo Nordisk wins FDA label expansion for Wegovy against liver disease MASHAugust 16, 2025 | msn.comInsider Selling: Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Director Sells 10,000 Shares of StockAugust 16, 2025 | insidertrades.comVanguard Group Inc. Sells 16,024 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)August 16, 2025 | marketbeat.comMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Director Sells $47,824,641.28 in StockAugust 15, 2025 | marketbeat.comInsider Selling: Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Director Sells 3,200 Shares of StockAugust 15, 2025 | marketbeat.comMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Director Sells $1,121,914.81 in StockAugust 15, 2025 | marketbeat.comMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Director Rebecca Taub Sells 43,263 SharesAugust 15, 2025 | marketbeat.comMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Director Sells $15,509,426.40 in StockAugust 15, 2025 | marketbeat.comMadrigal Pharmaceuticals: A High-Paced Launch That Could Grow FurtherAugust 15, 2025 | seekingalpha.comEntropy Technologies LP Makes New $365,000 Investment in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)August 15, 2025 | marketbeat.com Get Madrigal Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MDGL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MDGL Media Mentions By Week MDGL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MDGL News Sentiment▼0.890.99▲Average Medical News Sentiment MDGL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MDGL Articles This Week▼2310▲MDGL Articles Average Week Get the Latest News and Ratings for MDGL and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Madrigal Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Biogen News Today Incyte News Today United Therapeutics News Today Neurocrine Biosciences News Today BioMarin Pharmaceutical News Today Exelixis News Today Exact Sciences News Today Halozyme Therapeutics News Today Repligen News Today Ionis Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MDGL) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredThis strange black card is showing up across America"THIS is the Biggest Economic Story of 2025" While most Americans are focused on tariffs and inflation, the...Stansberry Research | SponsoredSmall Washington, DC Group Could Crash US StocksNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Madrigal Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Madrigal Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access